Dr. Paula R. Clemens

Jonathan Brent, MD, PhD, specializes in neuromuscular medicine and is board-certified in neuromuscular medicine and neurology by the American Board of Psychiatry and Neurology. He is affiliated with UPMC Mercy, UPMC Shadyside and UPMC Presbyterian. Dr. Brent received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and completed his residency and fellowship at McGaw Medical Center of Northwestern University Feinberg School of Medicine. Dr. Brent is rated as an Advanced provider by MediFind in the treatment of Myotonic Dystrophy. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Spinal and Bulbar Muscular Atrophy, and Myotonic Dystrophy Type 2.

David Lacomis, MD, is a neurologist and is certified in neurology, clinical neurophysiology, and neuromusculoskeletal medicine by the American Board of Psychiatry and Neurology. He is chief of the Division of Neuromuscular Diseases and director of clinical research for the Live Like Lou Center of ALS Research. He is also a professor of Neurology and Pathology at the University of Pittsburgh School of Medicine. He received his medical degree from Penn State College of Medicine and completed his residency at Brigham and Women’s Hospital, followed by his fellowship at the University of Massachusetts Medical Center. Dr. Lacomis is rated as a Distinguished provider by MediFind in the treatment of Myotonic Dystrophy. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myasthenia Gravis, Primary Lateral Sclerosis, Lambert-Eaton Syndrome, and Thymectomy.

Donald Tamulonis is a Neurologist and a Neuromusculoskeletal Medicine provider in Poland, Ohio. Dr. Tamulonis is rated as an Advanced provider by MediFind in the treatment of Myotonic Dystrophy. His top areas of expertise are Seizures, Autosomal Dominant Partial Epilepsy with Auditory Features, Memory Loss, and Infantile-Onset Spinocerebellar Ataxia (IOSCA). Dr. Tamulonis is currently accepting new patients.